TERAZOSIN

Product NDC: 51655-675
11-digit product format: 516550675
Labeler code: 51655
Product ID: 51655-675_f751ffef-914c-4e69-8073-75264391a5e2
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: terazosin hydrochloride
Dosage form: CAPSULE
Route: ORAL
Labeler: Northwind Pharmaceuticals, LLC
Application: ANDA075317
Marketing category: ANDA
Marketing start: 2015-02-27
Marketing end: 0000-00-00
Substance: TERAZOSIN HYDROCHLORIDE
Active strength: 2 mg/1
Pharmacologic classes: Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]
NDC exclude flag: No
Listing certified through: 2019-12-31
Current FDA listing: Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
51655-675-52	2026-01-06	C162847	48780-1	9d75b9d1-09ff-f424-e053-dadaa90a57ce	86702ee9-5ca0-40e3-831d-ca3a1c54ffe8
51655-675-52	2020-01-31	C162847	48780-1	9d75b9d1-09ff-f424-e053-dadaa90a57ce	86702ee9-5ca0-40e3-831d-ca3a1c54ffe8

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
51655-675	TERAZOSIN (TERAZOSIN HYDROCHLORIDE) CAPSULE [NORTHWIND PHARMACEUTICALS, LLC]	1	Legacy NDC	20150320_86702ee9-5ca0-40e3-831d-ca3a1c54ffe8.zip